Partners for research, AI strategy and implementation.

Carelane is a platform for clinical studies and registries. Protocol, data capture, analysis and study management sit in one system; the protocol is held as a structured document from which the case report forms are generated. It is used by pharmaceutical companies, contract research organisations, academic study groups and hospitals that want to run studies of their own.

Studies using existing care records start from discharge letters, pathology reports, imaging reports and scanned faxes. Aiomics turns them into structured, coded fields with their source. Which information is taken over, how it is checked and who signs it off is set by each research project, as are the study logic and the audit trail.

A study site can only offer evidence it is able to defend. For that, the origin of every single value has to be traceable. Both sides work on it from different ends.

The AI consultancy idalab works independently, with a focus on medicine and the life sciences. The team works for pharmaceutical and biotechnology companies, medical device manufacturers, care providers and investors: analysis pipelines in drug discovery, tools for market access and pricing, the approval pathway for products with an AI component, the assessment of holdings. Advice and building sit in the same hands, so a strategy does not end in a slide deck.

A hospital's AI question is bigger than documentation. The same meetings cover reading support in radiology, coding, staff scheduling, forecasting and voice assistance, alongside the rules that now apply to products with an AI component. Aiomics answers one part of that. The question about the whole is answered by idalab: what is worth doing, in what order, on what data foundation, and what has to be evidenced to the regulator.

We have worked with the same team for years. Idalab sells no software of its own and also assesses our platform against the requirements of each project.

INCH Health works on the question of why digital medical products convince in a pilot and then fade in daily practice. The team of clinicians and researchers addresses the usual causes: workflows that do not fit the product, participants with different expectations, missing measures, unclear ownership. It works through them in stages, from a short readiness assessment through a workshop to guidance for a whole roll-out. Alongside that, INCH brings hospitals, research and industry to one table, among other things in a standing forum on patient monitoring.

Implementation is part of what we deliver: a portal that carries a hospital through the first weeks, and a team that is reachable on the ward and shows how aiomics is used in daily practice. When a group introduces a system across many sites at once, or brings a bundle of different systems into operation, that is a job of its own with a method of its own. That is when we recommend INCH.

We have known the founder for close to a decade and have followed the work throughout. The team comes out of the clinic, and it shows in the questions it asks.